The Situation
A venture capital firm, specializing in life sciences and medical device companies, sought to evaluate a high-potential MedTech startup for its next major investment. They needed to perform due diligence thoroughly and ensure that there were minimal risk points within their portfolio.
To minimize risk within their portfolio, they turned to Peritia to perform due diligence on electronics, supply chain, manufacturing, and mechanical engineering functions within the MedTech firm in which they were considering investing.
The Solution
Peritia provided two expert consultants to perform due diligence on electronics, supply chain, manufacturing, and mechanical engineering. Together, they executed a detailed due diligence plan, after which they performed the following:
- Conducted a thorough assessment of printed circuit board assembly (PCBA) with respect to life cycle management and board design quality
- Assessed supply chain processes to identify vulnerabilities and strengths
- Analyzed manufacturing workflows for efficiency and compliance
- Coordinated real-time Q&A sessions between the investment team and company stakeholders to clarify findings and challenges
- Delivered a comprehensive final report with actionable recommendations to guide the investment decision
As the project progressed, the scope and timelines evolved based on new insights. BioBridges remained flexible to the changing needs of the VC firm while maintaining consistent standards.
The Results
The due diligence from Peritia provided the venture capital team the clarity and confidence needed to move forward. The firm proceeded with a $15 million investment in the MedTech company.
Hear from the client below on their experience working with BioBridges throughout this project:
“The [Peritia] team was responsive, thoughtful and insightful in our diligence project. They brought a valuable perspective to a critical aspect of our evaluation, enabling clarity and definition around timeline and technical risks. I would be pleased to work with them again.”